PT  - JOURNAL ARTICLE
AU  - Vinall, Phil
ED  - Verma, Sunil
TI  - Breast Cancer: Updated Overall Survival Results from EMILIA
DP  - 2012  01
TA  - MD Conference Express
PG  - 13--13
VI  - 12
IP  - 15
4099  - http://mdc.sagepub.com/content/12/15/13.1.short
4100  - http://mdc.sagepub.com/content/12/15/13.1.full
AB  - This article reports on updated study results of an Open-Label Study of Trastuzumab Emtansine versus Capecitabine+Lapatinib in Patients with HER2-Positive Locally Advanced or Metastatic Breast Cancer [EMILIA; NCT00829166] showing that progression-free survival and overall survival significantly improved in patients with breast cancer treated with trastuzumab emtansine compared with capecitabine plus lapatinib.